Evaluate the Safety and Efficacy of ALLN-177 in Patients with Enteric Hyperoxaluria: A Phase III Randomized, Placebo-Controlled Study

Administered By

Awarded By

Contributors

Start/End

  • June 7, 2018 - May 31, 2019